Yan Ni

6.4k total citations · 3 hit papers
120 papers, 4.5k citations indexed

About

Yan Ni is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Yan Ni has authored 120 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 24 papers in Epidemiology and 19 papers in Physiology. Recurrent topics in Yan Ni's work include Metabolomics and Mass Spectrometry Studies (29 papers), Liver Disease Diagnosis and Treatment (18 papers) and Diet and metabolism studies (16 papers). Yan Ni is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (29 papers), Liver Disease Diagnosis and Treatment (18 papers) and Diet and metabolism studies (16 papers). Yan Ni collaborates with scholars based in China, United States and Italy. Yan Ni's co-authors include Wei Jia, Mingming Su, Tianlu Chen, Aihua Zhao, Yunping Qiu, Guoxiang Xie, Runmin Wei, Jingye Wang, Shaoqiu Chen and Xiaojiao Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yan Ni

112 papers receiving 4.4k citations

Hit Papers

Missing Value Imputation Approach for Mass Spectrometry-b... 2018 2026 2020 2023 2018 2022 2024 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Ni China 36 2.6k 726 564 484 378 120 4.5k
Akiyoshi Hirayama Japan 32 3.2k 1.2× 997 1.4× 734 1.3× 447 0.9× 305 0.8× 116 4.9k
Zhiqiang Pang Canada 19 3.2k 1.2× 808 1.1× 398 0.7× 493 1.0× 196 0.5× 29 5.9k
Masakazu Shinohara Japan 38 2.2k 0.8× 660 0.9× 504 0.9× 457 0.9× 219 0.6× 172 4.8k
Hua Chen China 44 2.8k 1.1× 473 0.7× 405 0.7× 562 1.2× 400 1.1× 173 6.0k
Tianlu Chen China 37 3.2k 1.2× 966 1.3× 616 1.1× 842 1.7× 489 1.3× 102 5.2k
Uta Ceglarek Germany 42 2.1k 0.8× 871 1.2× 304 0.5× 510 1.1× 289 0.8× 200 5.3k
Othman Soufan Canada 14 3.1k 1.2× 530 0.7× 794 1.4× 394 0.8× 228 0.6× 19 5.0k
Mingming Su China 42 3.9k 1.5× 1.0k 1.4× 603 1.1× 967 2.0× 643 1.7× 126 6.3k
Kazutaka Ikeda Japan 36 4.1k 1.6× 815 1.1× 395 0.7× 442 0.9× 182 0.5× 95 6.2k
Vidya Velagapudi Finland 31 2.8k 1.1× 1.3k 1.8× 348 0.6× 953 2.0× 385 1.0× 71 4.6k

Countries citing papers authored by Yan Ni

Since Specialization
Citations

This map shows the geographic impact of Yan Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ni more than expected).

Fields of papers citing papers by Yan Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ni. The network helps show where Yan Ni may publish in the future.

Co-authorship network of co-authors of Yan Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Ni. A scholar is included among the top collaborators of Yan Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Ni. Yan Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Tengfei, Kechao Lu, Tao Feng, et al.. (2025). Phosphorus-induced single-atom iron coordination symmetry disruption for superior catalytic ozonation. Nature Communications. 16(1). 9037–9037. 1 indexed citations
2.
Leng, Lijun, et al.. (2025). Lithocholic Acid Species: Metabolism, Signaling Pathways, and Clinical Significance in Enterohepatic Diseases. International Journal of Molecular Sciences. 26(23). 11530–11530.
3.
Lv, Yao, Xiaoxi Wang, Jingan Lou, et al.. (2025). Ruminococcus torques ameliorates the inflammation bowel disease and gut barrier dysfunction by modulating gut microbiota and bile acid metabolism. Journal of Translational Medicine. 23(1). 1162–1162.
4.
Zhou, Xiaodong, Qin‐Fen Chen, Michael D. Shapiro, et al.. (2024). Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study. Diabetes Obesity and Metabolism. 26(9). 3684–3695. 8 indexed citations
5.
Yu, Gang, et al.. (2024). MetOrigin 2.0: Advancing the discovery of microbial metabolites and their origins. SHILAP Revista de lepidopterología. 3(6). e246–e246. 10 indexed citations
6.
Li, Yanmei, Xinyu Li, Yan Ni, et al.. (2024). Cascade STING activation of a ternary immunostimulant for colorectal cancer eradication via photodynamic DNA damage and T regulatory cell inhibition. Chemical Engineering Journal. 497. 154849–154849. 2 indexed citations
7.
Jin, Xing, Lei Liu, Dan Liu, et al.. (2024). Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma. Cell Death and Differentiation. 31(5). 558–573. 11 indexed citations
8.
Wang, Yanfei, Lei Hu, Jing Ye, et al.. (2024). Elevated total bile acid levels as an independent predictor of mortality in pediatric sepsis. Pediatric Research. 97(3). 1114–1121. 4 indexed citations
9.
Chen, Wen‐Ying, Jiahui Zhang, Lili Chen, et al.. (2024). Bioactive metabolites: A clue to the link between MASLD and CKD?. Clinical and Molecular Hepatology. 31(1). 56–73. 3 indexed citations
10.
Zhang, Danni, Huiying Wang, Shan Wang, et al.. (2023). The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry. 121. 109434–109434. 14 indexed citations
11.
Zhang, Yunjian, Yijie Li, Yan Ni, et al.. (2023). Long‐term effectiveness and seizure recurrence risk factors of ketogenic diet for pediatric refractory epilepsy: Experience from a tertiary care center in China. Epileptic Disorders. 25(6). 856–866. 2 indexed citations
12.
Sun, Dan‐Qin, Ling Jiang, Liang‐Jie Tang, et al.. (2023). Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 57(8). 872–885. 25 indexed citations
13.
Wang, Shan, Rahim Ullah, Xinyi Liang, et al.. (2023). Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study. Hepatology International. 18(1). 179–187. 9 indexed citations
14.
Yu, Gang, et al.. (2022). MetOrigin: Discriminating the origins of microbial metabolites for integrative analysis of the gut microbiome and metabolome. SHILAP Revista de lepidopterología. 1(1). e10–e10. 143 indexed citations breakdown →
15.
Lv, Yao, Qi Cheng, Jingan Lou, et al.. (2022). The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease. Clinical Nutrition. 42(2). 116–128. 12 indexed citations
16.
Ni, Yan, Gang Yu, Huan Chen, et al.. (2020). M2IA: a web server for microbiome and metabolome integrative analysis. Bioinformatics. 36(11). 3493–3498. 53 indexed citations
17.
Dai, Weixing, Ye Xu, Shaobo Mo, et al.. (2020). GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies. Signal Transduction and Targeted Therapy. 5(1). 177–177. 90 indexed citations
18.
Xiao, Ling, Qiuming Yao, Yan Ni, et al.. (2017). A case–control study of selenoprotein genes polymorphisms and autoimmune thyroid diseases in a Chinese population. BMC Medical Genetics. 18(1). 54–54. 9 indexed citations
19.
Ni, Yan. (2010). The value of HbA1c for diagnosing type 2 diabetes in high-risk population. Xi'an Jiaotong Daxue xuebao. 1 indexed citations
20.
Ni, Yan. (2008). Study of Quality Standard for Qingfei Yihuo Tablet. Zhongguo zhongyiyao xinxi zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026